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Muscle pathology from stochastic low level DUX4
expression in an FSHD mouse model
Darko Bosnakovski1,2,3, Sunny S.K. Chan1,2, Olivia O. Recht1,2, Lynn M. Hartweck1,2, Collin J. Gustafson1,2,
Laura L. Athman1,2, Dawn A. Lowe4 & Michael Kyba 1,2
Facioscapulohumeral muscular dystrophy is a slowly progressive but devastating myopathy
caused by loss of repression of the transcription factor DUX4; however, DUX4 expression is
very low, and protein has not been detected directly in patient biopsies. Efforts to model
DUX4 myopathy in mice have foundered either in being too severe, or in lacking
muscle phenotypes. Here we show that the endogenous facioscapulohumeral muscular
dystrophy-speciﬁc DUX4 polyadenylation signal is surprisingly inefﬁcient, and use this ﬁnding
to develop an facioscapulohumeral muscular dystrophy mouse model with muscle-speciﬁc
doxycycline-regulated DUX4 expression. Very low expression levels, resulting in infrequent
DUX4 +myonuclei, evoke a slow progressive degenerative myopathy. The degenerative
process involves inﬂammation and a remarkable expansion in the ﬁbroadipogenic progenitor
compartment, leading to ﬁbrosis. These animals also show high frequency hearing deﬁcits
and impaired skeletal muscle regeneration after injury. This mouse model will facilitate in vivo
testing of therapeutics, and suggests the involvement of ﬁbroadipogenic progenitors in
facioscapulohumeral muscular dystrophy.
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Facioscapulohumeral muscular dystrophy (FSHD) is one ofthe most prevalent muscle diseases, affecting an estimatedhalf million individuals1. The disease is dominant, caused
by mutations disrupting epigenetic silencing of the D4Z4
macrosatellite repeat at 4qter2–6: usually reductions in D4Z4
copy number7, but also second site mutations in epigenetic
regulators6, 8. Disrupted silencing on a speciﬁc allelic background,
which provides a downstream poly A signal9, leads to expression
of DUX4, whose ORF is embedded in each D4Z4 repeat
and encodes a double homeodomain transcription factor9–11, and
to activation of DUX4 target genes12 through a mechanism
involving p300/CBP13.
Although DUX4 target genes are detectable in FSHD biopsy
specimens14, the DUX4 protein itself has not been detected by
immunostaining, meaning that its expression is either very low;
or stochastic, infrequent and possibly followed by cell death.
In cultured FSHD myoblasts, DUX4 can be detected in at most
1/1000 cells15, 16, but is more frequent upon differentiation into
myotubes17. Forced high-level DUX4 expression causes death of
myoblasts in vitro, while low-level expression prevents their
differentiation18.
The lack of a genetic mammalian model in which to study
DUX4-mediated muscle pathology, and to test therapeutic
interventions targeting DUX4, is currently a major roadblock
in understanding of and developing treatments for FSHD.
DUX4/D4Z4 transgenic mice have to date either lacked a muscle
phenotype19, or displayed such a strong multisystem phenotype
that most die as embryos and rare live-born animals die before
adult muscle develops20. The latter mouse, named iDUX4[2.7]
carried a doxycycline-inducible DUX4 gene followed by the SV40
poly A signal integrated onto the X chromosome. Females
showed severely biased X-inactivation of the DUX4-bearing X,
presumably due to the competitive advantage that DUX4-X-
inactivated cells have over those that inactivate the wild-type
(WT) X during embryogenesis, thus females propagated the
strain but were not themselves suitable for analysis. In the current
study, we ﬁnd that by changing the polyadenylation signal used in
this X-linked transgene, basal expression in the off state is
reduced and the multisystem phenotype is ameliorated. This
new mouse model now enables growth to adulthood and the
study of muscle-speciﬁc expression of DUX4 in both males and
females. We ﬁnd that very low levels of DUX4 expression in
skeletal muscle ﬁbers lead to an expansion in the ﬁbroadiopgenic
progenitor compartment, and to a progressive ﬁbrotic degen-
eration of skeletal muscles.
Results
The endogenous DUX4 polyadenylation signal is inefﬁcient.
FSHD only occurs when the derepressed D4Z4 array is present
upstream of a permissive (4qA) allele, the deﬁning feature of
which is a polyadenylation signal that is thought to provide sta-
bility to the message and thereby allow translation of the DUX4
protein9. In the iDUX4[2.7] mouse, this sequence was present
together with an additional SV40 poly A (Fig. 1a). Because read
through transcription of the DUX4 poly A in the iDUX4[2.7]
model would be stabilized by the SV40 poly A, measuring mRNA
upstream and downstream of the 4qA poly A in this context is a
sensitive way of quantifying its activity. We discovered signiﬁcant
read through of the endogenous DUX4 pA (Fig. 1b), and hypo-
thesized that the SV40 pA may provide disease-inappropriate
stability to the DUX4 message in the iDUX4[2.7] mouse.
Therefore, we generated a doxycycline-inducible DUX4 model
lacking the SV40pA. A genomic fragment from the terminal
D4Z4 repeat of an FSHD 4qA161 allele including the DUX4 ORF,
3ʹ UTR and DUX4 pA was introduced at the same location
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Fig. 1 DUX4 poly A signal read through and the effect of removing the
SV40 pA signal. a Schematic of transgene integration in iDUX4[2.7]
mice and primers/probe used for detection of transcript proximal to
and distal of the DUX4 pA signal. Note the SV40 poly A signal
downstream of the DUX4 poly A signal. b RTqPCR with reverse
primers on either side of the DUX4 pA signal in PDGFRα+ integrin
α7– (ﬁbroadiopgenic) and PDGFRα– integrin α7+ (myogenic) sorted
cultured primary muscle cells. n = 3 technical replicates. Note the large
amount of transcript that is detected by the primer downstream of the
DUX4 pA, indicating that the DUX4 poly A is not efﬁcient and allows a
high level of read through. In the iDUX[2.7] mouse, these read through
transcripts are stabilized by the SV40 poly A, potentiating higher basal
levels of DUX4 in the off state. c The transgene is targeted 5ʹ of HPRT, is
regulated by a second generation tetracycline-response element,
includes DUX4 and 3ʹ UTR including the DUX4 poly A signal. d Mice
were made in which the SV40 pA was removed, leaving only the
endogenous, less efﬁcient, DUX4 pA. Viability is now near-normal for
male carriers. Summary of 174 genotypes of 3-week old mice from 21
litters of iDUX4pA females backcrossed to males with a WT chrX.
Results are not signiﬁcantly different from expected for the hypothesis of
no selection against iDUX4pA ( χ2, two tailed p = 0.2956), but are
strongly diverged from expected (p < 0.0001) for the hypothesis that
iDUX4pA is selected against at the same level as observed against
iDUX4[2.7]20. Thus, we conclude that the presence of the DUX4 poly A
makes the transgene less toxic, with viability to 3 weeks not different
from WT in the absence of dox
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upstream of HPRT under the control of the doxycycline-inducible
promoter. We refer to this strain as iDUX4pA (Fig. 1c). Unlike
the previous iDUX4[2.7] line in which live-born carrier males are
rare and die as weanlings, iDUX4pA males survive to 3 weeks at
near-normal ratios (Fig. 1d).
Muscle phenotypes in the absence of doxycycline. Carrier males
grow well, but have a slightly reduced body weight and live up to
4 months, while females appear normal (Fig. 2a). Like the iDUX4
[2.7] strain, the iDUX4pA mice have skin hyperkeratosis and
alopecia. Males have much reduced body fat (Supplementary
Fig. 1a), although they eat normally. Male muscles appeared
atrophic, and proportional to body weight, were signiﬁcantly
smaller (Fig. 2b), more obvious if normalized to lean body weight
since these animals have little fat (Supplementary Fig. 1b).
Although capable of normal ambulation, males were less active
overall (Supplementary Fig. 1c), and showed signiﬁcant defects
on functional strength and locomotor measurements (Fig. 2c).
The contractile strength of the isolated extensor digitorum longus
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muscle (EDL) was signiﬁcantly diminished, and it showed lower
speciﬁc isometric force signiﬁcantly decreased rate of contraction
and extended relaxation time (Fig. 2d, Supplementary Fig. 2a).
The muscle did not show obvious histological signs of dystrophy,
however analysis of cellular composition by ﬂow cytometry
revealed a large increase in Linneg (CD45neg and CD31neg)
integrin α7neg PDGFRα+ presumptive ﬁbroadipogenic progeni-
tors (FAPs)21, 22 (Fig. 2e, Supplementary Fig. 3a, b). We did not
detect a signiﬁcant change in the frequency of Linneg integrin α7+
VCAM+ myogenic progenitors or CD45neg CD146+ CD31+
pericytes (Supplementary Fig. 3c, d). However, small but signiﬁ-
cant alterations of CD45neg Sca1+ CD31+ endothelial progeni-
tors23 and CD206+ macrophages were detected (Supplementary
Fig. 3e, f). DUX4 mRNA could be detected at extremely low levels
by RTqPCR and its targets Myo1g and Wfd3c were elevated
(Fig. 2f, Supplementary Fig. 4). Additional transcriptional ana-
lyses in muscle revealed induction of some genes involved in
ﬁbrosis and reduced expression of MyoD (Fig. 2f). Extremely low
DUX4 basal expression together with elevated levels of DUX4
targets were also detected in some non-muscle tissues in males
(Supplementary Fig. 4). iDUX4pA females presented milder skin
phenotypes, and did not display muscle atrophy or decreased
functional strength or muscle contractile force (Fig. 2c, Supple-
mentary Fig. 2b).
Evaluation of high frequency hearing loss. High frequency
hearing loss is a non-muscle phenotype associated with FSHD24, 25.
We therefore evaluated the auditory brainstem response (ABR) of
iDUX4pA mice to sounds of increasing amplitude across a range of
frequencies. This revealed that both male and female iDUX4pA
mice are hearing-impaired, particularly at the higher frequency
ranges, with males being more severely affected and deaf to sounds
of 16 kHz and above (Fig. 2g).
Muscle-speciﬁc DUX4 induction leads to dystrophic changes.
To evaluate DUX4 effects in muscle, we ﬁrst investigated the
effect of DUX4 expression on primary cultured cells from muscle
using the ubiquituously expressed Rosa26-rtTA2sM2 driver26.
As previously demonstrated, DUX4 displayed cytotoxicity to both
myogenic (VCAM1+ integrin α7+) and ﬁbroadipogenic (integrin
α7neg PDGFRα+) progenitors when induced to high levels
of expression (Supplementary Fig. 5), and impaired myogenic
differentiation at low levels of expression (Supplementary Fig. 6).
With the ubiquitous rtTA, animals died within 24 h of
dox treatment, therefore to evaluate the effects of DUX4
induction on muscle in vivo, we replaced the Rosa26-rtTA driver
with the skeletal muscle-speciﬁc HSA-rtTA driver27. Exposure of
6-week-old male mice to doxycycline led to signiﬁcant reductions
in muscle size in a dose- and time-dependent manner (Fig. 3a, b).
Muscles showed differential sensitivity, with gastrocnemius/
soleus and quadriceps being highly sensitive and TA muscle less
so. Remarkably, similar sensitivities were observed in females,
whose muscles are normal in size prior to induction (Supple-
mentary Fig. 7a). Doxycycline had no effect on muscle size
of mice lacking HSA-rtTA. We measured force-generation
capacity of the isolated EDL and found absolute force reduced
by ∼50% after 28 days of low (5 mg/kg) dox, with signiﬁcantly
decreased speciﬁc tetanic, isometric and concentric force (Fig. 3b,
Supplementary Fig. 8).
We investigated DUX4 expression and found that most ﬁber
nuclei were negative, but sporadic nuclei were DUX4+ with
varying staining intensities (Fig. 3c). Expression was not observed
in interstitial cells, and positive nuclei were generally surrounded
by MHC + cytoplasm (Supplementary Fig. 7b). DUX4 mRNA and
upregulation of DUX4 target genes were robustly detected in
muscle but not in liver (Fig. 3d).
Coincident with these physiological changes, we observed
dystrophic changes to muscle: excessive heterogeneity of ﬁber size
including many small ﬁbers, damaged and necrotic ﬁbers,
mononuclear cell inﬁltrate, a large excess of extracellular matrix
deposition between ﬁbers and some central nucleation, in both
males and females (Fig. 3e, Supplementary Fig. 7c). This situation
is strongly reminiscent of FSHD patient biopsies, where
histological signs are obvious, the DUX4 target gene expression
proﬁle is detectable, but the DUX4 protein has proven very
difﬁcult to identify by immunohistochemistry.
We quantiﬁed the ﬁbrotic changes in the gastrocnemius, and
found that extremely high induction (100 mg/kg dox) led to
∼15% of muscle cross-sectional area turning over to ﬁbrotic tissue
within 14 days (Fig. 3e). We also observed an increase in mRNAs
associated with a ﬁbrotic program, including TGFβ1 and Col1a1
(Fig. 3f). We did not detect signiﬁcant increases of PDGFRα+ and
Sca1+ cells with DUX4 induction (Supplementary Fig. 8), most
likely, because those progenitors were already very high in
iDUX4pA males compared to WT (Fig. 2f, Supplementary
Fig. 3b). In females on the other hand, where FAP frequencies
were much lower prior to induction, a signiﬁcant induction
of FAPs was detected in response to DUX4 in a dose- and
time-dependent manner (Supplementary Fig. 10).
Inﬂammatory cells can stimulate the pro-ﬁbrotic activity of
FAPs28, therefore we evaluated muscle by ﬂow cytometry for
markers of inﬂammatory myeloid cells. This revealed a large
increase in frequency of CD45 cells expressing the markers Ly6G,
CD68, and CD206 after dox induction, consistent with this
notion (Fig. 3g, Supplementary Fig. 11).
DUX4 induction severely impairs regeneration after injury.
Because DUX4 expression inhibits myogenesis, it has been
proposed that impaired regeneration after normal wear and tear
or injury could contribute to muscle loss in FSHD18. To test the
effect of DUX4 on skeletal muscle regeneration after injury, we
damaged TA muscles of HSA-rtTA; iDUX4pA male and female
Fig. 2 Phenotypes of iDUX4pA mice in the basal “off” state. a Weekly average of the weight of iDUX4 and wild type (WT) male and female siblings
(n= 3–25). b Normalized mass to the body weight (BW) of various muscles in iDUX4pA males. Extensor digitorum longus (EDL), tibialis anterior (TA),
gastrocnemius and soleus (G/S), quadriceps (Quad), triceps brachii (Triceps), pectoralis, psoas major (Psoas), and masseter from 10 to 15 week old mice
and age-matched siblings are analyzed (n= 10). c Representative example of hanging wire, grip strength and rotarod analyses of 6-week-old iDUX4pA
male and female mice (n= 4). d Speciﬁc force, time to reach peak twitch force (TPT) and time to reach 1/2 relaxation during twitch (1/2 TPT) of EDL in
6–10-week-old iDUX4pA males and age-matched siblings (n= 8). e Representative FACS analyses for Linneg (CD45neg; CD31neg) and PDGFRα+ or Sca1+
cells in muscle from iDUX4pA males and sibling controls. Percent of PDGFRα+ or Sca1+ cells in pooled muscle digests comprising TA, gastrocnemius,
soleus, quadriceps, pectoralis, and triceps is shown at right (n= 7). f RTqPCR analyses for DUX4, DUX4 targets, myogenic genes, and genes involved in
ﬁbrosis in pectoralis from iDUX4pA male mice. Results are presented as fold difference to GAPDH (n= 4). g Auditory brainstem response (ABR) in iDUX4
males, females and WT sibling controls (n= 5, 6–8 week old mice). Note that iDUX4pA males do not respond to sounds of 16 kHz and above and
iDUX4pA females to sounds of 32 kHz. All data are presented as mean±SEM; *p< 0.05, **p< 0.01, ***p< 0.001, ****p< 0.0001 by T-test or g two-way
ANOVA followed by Tukey’s post hoc test
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animals by cardiotoxin injection. In the presence of dox to induce
DUX4, 1 month post-injured muscles showed only small
ﬁbers, together with severe ﬁbrosis in the zone of injury (Fig. 4a,
Supplementary Figs. 12, 13). Immunostaining revealed
stochastic but more prominent DUX4 expression in cells in the
injured area, compared to differentiated ﬁbers in the uninjured
area. In the mouse, cardiotoxin-injured TA muscles undergo mild
hypertrophy to recover to slightly greater than pre-injury mass
within 3 weeks. We found that this did not occur in the presence
of DUX4, rather we saw instead a large and dose-dependent loss
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of muscle mass (Fig. 4b–d). Thus, not only does DUX4 expression
in established ﬁbers lead to dystrophy, but DUX4 expression in
differentiated myogenic cells in the context of regeneration leads
to profoundly severe dystrophic changes.
Discussion
The DUX4 poly A signal is ATTAAA, which is more subject to
alternative usage than the more common AATAAA29, which may
explain why it allows signiﬁcant read-through. By making DUX4
expression dependent on its endogenous relatively inefﬁcient pA,
we have reduced the basal off-state activity and eliminated the
dominant lethality of the inducible DUX4 transgene. With a
ubiquituous rtTA driver, mice die within 24 h of dox treatment,
however with the skeletal muscle-speciﬁc
HSA-rtTA, mice survive beyond 5 weeks without obvious
phenotypes outside of the muscle, demonstrating the tightness
of the system. The skeletal muscle pathologies acquired upon
doxycycline induction demonstrate a remarkable and important
similarity to the most unusual aspect of FSHD: in human
muscle biopsies, the DUX4 protein is virtually invisible by
immunohistochemistry, although its RNA and target gene
signature can be detected. Likewise, the DUX4 target gene
signature is detectable at the RNA level in the uninduced
iDUX4pA mouse, but the DUX4 protein is not visible by
immunohistochemistry. This very low expression may be due to
the low efﬁciency of the inducible system in skeletal muscle
ﬁbers, and/or to the unexpected inefﬁciency of the endogenous
DUX4 4qA161 poly A signal. Nevertheless, muscles are wasted,
proportionally smaller and weaker. After induction, DUX4 is only
expressed in a small minority of myonuclei, yet this increase in
expression leads to devastating dystrophic changes over a period
of several weeks.
The mice also exhibit another notable FSHD-associated
phenotype—high frequency hearing loss. This phenotype occurs
in the absence of induction, i.e., with low, protein-undetectable
levels of DUX4 from the basal “off” state of the dox-inducible
promoter.
The iDUX4pA model is both conditional and titratable, thus
both the timing of onset of muscle loss and its severity can be
controlled. At low induction levels, chronic atrophy leading to
muscle weakness ensues, while at high induction levels, more
severe muscle damage occurs leading to loss of ambulation.
This titratability is particularly relevant to FSHD as the disease
presents with wide variability in both severity and age of onset.
Although the iDUX4pA transgene is X-linked, induced females
showed robust loss of muscle function with no greater variance
than males. We attribute this to the granularity of X-inactivation
combined with the large number of myonuclei per ﬁber. This
leads to the likelihood that most ﬁbers contain a subpopulation of
nuclei with DUX4-bearing active X chromosomes. The robust
ability to induce phenotypes at FSHD-relevant levels of DUX4
expression in both males and females is well-suited to testing
therapeutics targeting the DUX4 protein or mRNA.
Notwithstanding the striking similarities to FSHD described
above, the iDUX4pA mouse does not show certain hallmarks of
the disease, such as the spatial pattern of affected muscles. These
are partly by design (phenotypes are limited by the spatial activity
of the conditional promoter used), but may also relate to the fact
that a large set of DUX4 target genes are regulated in humans but
not mice30. However, given the striking phenotypes observed,
those targets that are in common between the two species must
explain the major component of pathology, with differences
possibly explaining the subtleties.
The pathological sequence by which DUX4 leads to muscle
wasting in FSHD is currently enigmatic. Previous FSHD
transgenic mouse models have not been useful as they have
shown no muscle phenotypes19, 20 or have overexpressed the
wrong gene31. However, relevant disease mechanisms can now
be probed. We found that although muscle of iDUX4pA
males showed no signs of frank dystrophy prior to induction,
it harbored an excess of PDGFRα+ FAPs, suggesting that the
lowest levels of DUX4 expression set up a proﬁbrotic state.
After doxycycline treatment to stochastically induce IHC-visible
levels of DUX4 in ﬁbers, muscles experience an inﬂux of
inﬂammatory cells and the initiation of a ﬁbrotic program. Since
DUX4 induction was conﬁned to myoﬁbers, this effect is
most likely non-cell autonomous. Muscle tissue is lost, and
myogenesis increases, but myogenesis clearly cannot
compensate productively, with the end result being severe loss of
force-generation capacity. We directly tested the effectiveness
of myogenesis by cardiotoxin injury and found that it was
profoundly impaired in both males and females. The ability to
combine with different rtTA drivers will allow the iDUX4pA
model to be used to investigate potential pathological roles
for DUX4 expression in myogenic progenitors and other cells
of muscle. The involvement of FAPs in response to DUX4
expression in muscle clearly warrants considering non-cell
autonomous mechanisms in FSHD32 and investigations into
FAPs in FSHD biopsy material.
The absence of a suitable animal model has to date
severely limited both investigations into disease mechanisms and
investment in pharmacological therapies for FSHD. The
iDUX4pA mouse, with disease-relevant low-level and stochastic
DUX4 expression, and conditional titratable muscle phenotypes
will facilitate these efforts.
Methods
Targeting construct cloning and generation of iDUX4pA mice. The SV40 pA
signal was deleted from p2Lox-DUX420 and the resulting plasmid introduced by
electroporation into ZX1 inducible cassette exchange mouse ES cells33. Chimeric
animals were derived at the University of Minnesota Mouse Genetics Laboratory
Core Facility by blastocyst injection. Mice were maintained under a protocol
approved by the University of Minnesota IACUC. These mice have been assigned
Stock No. 030749 (Jackson Labs).
Fig. 3 DUX4 induces skeletal muscle atrophy. a Mass of various muscles normalized to the body weight (BW) of iDUX4pA male mice treated
with doxycycline over doses and time ranges (n= 3). b Speciﬁc isometric, concentric and eccentric forces and 1/2 relaxation time (1/2 TPT) of EDL in
10-week-old iDUX4pA male mice induced with 5mg/kg doxycycline for 28 days (n= 4). c Immunostaining for DUX4 and laminin on quadriceps of
iDUX4pA;HSA-rtTA males induced with 5 and 100mg/kg doxycycline for 14 days. DAPI was used for nuclear staining. d RTqPCR analyses for DUX4 and
DUX4 target genes Myo1g, Wfdc3, Azi2, Cdkn1a, and Zscan4c in pectoralis muscle and liver of iDUX4pA;HSA-rtTA male mice induced with 25mg/kg
doxycycline for 14 days. Results are presented as fold difference to GAPDH (n= 3). e Hematoxylin and Eosin (H&E) staining and Sirius red/fast green
staining of quadriceps from iDUX4pA;HSA-rtTA male mice induced with 5 and 100mg/kg doxycycline for 14 days (left). Quantiﬁcation of ﬁbrous tissue in
control and induced (100mg/kg) quadriceps (n= 3, right). f RTqPCR for indicated ﬁbrogenic markers in iDUX4pA;HSA-rtTA males mice induced with
5mg/kg doxycycline for 14 days. Results presented as fold difference to GAPDH (n= 3). g Representative FACS analyses for hematopoietic inﬂammatory
cells expressing CD45 and CD68, CD206 or Ly6G in muscle of iDUX4pA;HAS-rtTA males or control siblings (WT or lacking rtTA) induced with 25mg/kg
doxycycline for 14 days (left), and summary data (right, n= 4). Data are presented as mean±SEM; *p< 0.05, **p< 0.01, ***p< 0.001, ****p< 0.0001 by
T-test except a, b two-way ANOVA or g one-way ANOVA, with Tukey’s post hoc test
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Fig. 4 DUX4 impairs recovery after injury. a Hematoxylin and eosin (H&E), Sirius red/fast green and immunostaining for DUX4, Laminin and DAPI nuclear
staining of uninjured and injured TA muscle sections from iDUX4pA;HSA-rtTA males and controls lacking rtTA 12 days post injury. Mice were induced
with 25mg/kg doxycycline for 12 days. b Gross morphology of injured/uninjured TA muscles with/without DUX4 induction 12 days post injury. c Ratio of
weight of post injury vs. uninjured contralateral TA from iDUX4pA;HSA-rtTA males, and siblings lacking rtTA or fully WT 12 days post injury (n= 3).
d Ratio of post injury vs. uninjured contralateral TA from iDUX4pA;HSA-rtTA male and female mice 12 days post injury. Mice were induced with 25mg/kg
doxycycline (n= 3). Data are presented as mean±SEM; **p< 0.01, ****p< 0.0001 by c one-way ANOVA with Tukey’s post hoc test or d T-test
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RNA isolation and RTqPCR. RNA was isolated from snap frozen muscles or
cultured cells using Trizol (Invitrogen) according to the manufacturer’s directions.
In total, 3 µg RNA was treated with DNase (Promega), and cDNA was synthetized
using SuperScript IV Reverse Transcriptase (Invitrogen). qPCR was performed
using Premix Ex Taq (Probe qPCR) Master Mix (Takara) and commercially
available TaqMan probes (Applied Biosystems, see Supplementary Table 1), except
for DUX4 which was detected using FAM-labeled probe (TCTCTGTGCCCTTG
TTCTTCCGTGAA) and custom primers (PLH298-PAS-F: CCCAGGTACCAGCA
GACC and PLH299-PAS-R: TCCAGGAGATGTAACTCTAATCCA, from9)
detecting 3ʹ UTR sequences upstream of the pA signal or an alternative reverse
primer (PLH300-DAS-R: TGATCACACAAAAGATGCAAATC) for detecting
read through transcription. Expression analyses were performed on at least three
biological and technical replicates.
Isolated skeletal muscle contractile measurements. Intact EDL muscles were
dissected from anesthetized mice and placed in a tissue bath ﬁled with Krebs-
Ringer bicarbonate buffer. The distal tendon was statically attached to the bottom
of the bath and the proximal tendon to a lever. Contractions were induced using a
Grass S48 stimulator delivered through a SIU5D stimulus isolation unit (Grass
Telefactor), and forces measured using a dual-mode muscle lever system (300B-LR;
Aurora Scientiﬁc Inc.) and TestPoint software (Capital Equipment), as described in
ref. 34.
Body composition and measurement of mouse activity. Cage activities were
analyzed over a period of 72 h in open ﬁeld activity chambers (Med Associates Inc.,
St. Albans, VT) and body composition was evaluated with Echo-MRI (Echo
Medical Systems) at the IBP Phenotyping Core Facility, University of Minnesota.
Hanging wire test. The hanging wire test was adapted from Kondziela’s inverted
screen test. Mice were placed in the center of a framed wire mesh and the frame
was inverted. The time that the mice clung to the wire was recorded. Scores for
each mouse were averages of three tests.
Grip strength test. The weights test was done using seven different weights,
ranging from 7 g to 98 g. Mice were suspended by the tail and allowed to grip with
forepaws a tangled ball of ﬁne gauge wire, attached to the lowest weight. Mice were
moved to a greater weight if they held the tested weight three times for 3 s, with a
10 s break between each trial. The ﬁnal score was the greatest weight held three
times for 3 s.
Rotarod test. The rotarod test was run using a Rota Rod Rotamex 5 (Columbus
Instruments). The rotarod was programmed to start at 10 rpm, and increased 5
rpm every 30 s. Average length of time spent on the rotarod from three replicates
was recorded.
Isolation and FACS analyses of mononuclear cells from muscle. Pooled or
individual muscles (TA, gastrocnemius, soleus, quadriceps, pectoralis, triceps)
were minced and digested with collagenase type II and dispase. Levels of muscle
inﬁltration with hematopoietic cells and FAPs were evaluated using FACS and
following antibodies CD45, CD31, CD206, CD68, Ly6G, PDGFRα, Sca1, VCAM1,
CD11b, CD144, CD146, and integrin α7 (Supplementary Table 2). Staining was
done in PBS supplemented with 1% FBS on ice for 60 min. Samples were analyzed
on a FACSAria and data analyzed using FlowJo (BD Biosciences). FACS gating
strategy is shown in Supplementary Fig. 3a. All experiments were done on at least
three biological replicates.
Primary cultures of myogenic progenitors and FAPs. Total muscle digests were
plated in Ham’s F-10 medium (Hyclone) supplemented with 20% fetal bovine
serum (HyClone), 50 ng/μl human basic ﬁbroblast growth factor (Peprotech),
penicillin, streptomycin, and Glutamax (Gibco), and cultured at 37°C in 5% oxy-
gen. After 5–7 days, myogenic progenitors were sorted out as CD45neg CD31neg
integrin α7+ VCAM1+ and FAPs as CD45neg CD31neg integrin α7neg PDGFRα+
cells using a FACSAria (BD Biosciences).
Auditory evoked brainstem response analyses. Hearing loss was done on
ketamine/xylazine anesthetized mice on a BioSigRP TDT System 3 (Tucker-Davis
Technology; Alachua, FL). Stimuli were presented as a Pure Tone and responses to
500 sweeps were averaged at each intensity level (frequencies from 4 kHz to 32 kHz
and 10-dB SPL steps). The auditory threshold was deﬁned as the lowest intensity
level at which a clear ABR waveform was visible.
Histology and immunoﬂuorescence. Muscles were embedded in OCT. All his-
tological staining was done on 10 µm tissue sections. Fibrosis was visualized by
Sirius red/fast green staining and the level of ﬁbrosis determined using ImageJ
Software35. Immunostaining was performed on 10% formalin ﬁxed tissue sections
or on cells cultured in 48-well plates. Samples were permeabilized with Triton-X,
blocked with 3% BSA, incubated with primary antibody overnight, and
ﬂuorochrome-conjugated secondary antibodies (Invitrogen) for 45 min. Nuclei
were stained with DAPI (Sigma). Antibodies used for immunoﬂuorescence are
shown in Supplementary Table 2.
Statistics. To minimize selection bias, randomization was done by selecting pairs
of animals of identical age and similar weight, and distributing between two groups
blinded to group treatment. Experimenters were also blinded to group allocation
during processing and analysis of samples. All replicates are biological, except
where indicated. Sample sizes were selected based on effect size and availability of
experimental/sibling control animals. Group data was tested for normality
(Kolmogorov–Smirnov test) and differences between groups were evaluated by
T-test (if not indicated), χ2 test, or two-way analysis of variance (ANOVA)
followed by Tukey’s or Sidak’s post hoc tests as indicated, using Graphpad Prism
software. Differences were considered signiﬁcant at p-values of 0.05 or lower.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author upon reasonable request.
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